MaxCyte regains Nasdaq compliance after stock price recovery
MaxCyte received notice on June 10, 2026, from Nasdaq that the company has regained compliance with the minimum bid price requirement under Listing Rule 5450(a)(1) after the closing bid price of its common stock remained at $1.00 or greater for 10 consecutive business days from May 27, 2026, to June 9, 2026. The company had fallen out of compliance in March 2026 when its stock closed below $1.00 per share for 30 consecutive trading days, triggering a delisting notice; the June determination closes that matter.
Key facts
- Closing bid price fell below $1.00 per share for 30 consecutive trading days, triggering non-compliance notice on March 16, 2026
- Regained compliance with closing bid price at $1.00 or greater for 10 consecutive business days from May 27, 2026, to June 9, 2026
- Nasdaq Listing Rule 5450(a)(1) minimum bid price requirement
- Nasdaq delisting notice received March 20, 2026
- Compliance determination and closure of matter received June 10, 2026
Why it matters
MaxCyte has resolved its listing threat and no longer faces imminent delisting risk, restoring its status on the Nasdaq Global Select Market after a three-month compliance breach.
Developing story
- SCHEDULE 13D
- 8-Kthis filing
Share
Get the next chapter in your inbox — a Sentinel watches this company and briefs the next material filing the moment it lands.
Derived from 8-K filed 2026-06-16. Not investment advice. View the source filing on SEC.gov →